FBTDX Mutual Fund

FBTDX Mutual Fund (Franklin Biotechnology Discovery Fund Class C) is managed by Franklin Templeton Investments (US) with $46.6M in net assets. FBTDX expense ratio is 1.77%, holding 98 positions across sectors including Health Care, Financials. Inception date: 2014-03-04.

FBTDX performance shows a YTD return of 17.26%. The 1-year return is 70.17% and the 5-year return is 11.01%. FBTDX dividend yield stands at 1.52%, paid annually.

FBTDX top holdings include Gilead Sciences (6.2%), Amgen Inc. (4.8%), Nvaesrtex Pharmaceuticals Inc (4.7%), Jazz Pharmaceuticals Plc. (4.6%), Regeneron Pharmaceuticals, Inc. (4.4%). Go to all FBTDX holdings, FBTDX sectors, or FBTDX dividends.

FBTDX can be compared against other funds. Use FBTDX overlap to find shared positions, or FBTDX vs another fund for a side-by-side view. FBTDX alternatives are available via the screener, along with tax-loss harvesting opportunities.